Helius Medical Technologies Inc (NASDAQ:HSDT) has a beta value of 1.62 and has seen 0.87 million shares traded in the recent trading session. The company, currently valued at $3.05M, closed the recent trade at $0.85 per share which meant it gained $0.09 on the day or 11.48% during that session. The HSDT stock price is -1480.0% off its 52-week high price of $13.43 and 23.53% above the 52-week low of $0.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 59160.0 shares traded. The 3-month trading volume is 88.89K shares.
The consensus among analysts is that Helius Medical Technologies Inc (HSDT) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -1.06.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Sporting 11.48% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the HSDT stock price touched $0.85 or saw a rise of 10.53%. Year-to-date, Helius Medical Technologies Inc shares have moved -89.41%, while the 5-day performance has seen it change 9.78%. Over the past 30 days, the shares of Helius Medical Technologies Inc (NASDAQ:HSDT) have changed 24.86%. Short interest in the company has seen 31313.0 shares shorted with days to cover at 0.37.
Helius Medical Technologies Inc (HSDT) estimates and forecasts
The company’s shares have lost -85.32% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 13.40%.
1 analysts offering their estimates for the company have set an average revenue estimate of 150k for the current quarter. 1 have an estimated revenue figure of 270k for the next ending quarter. Year-ago sales stood 143k and 134k respectively for this quarter and the next, and analysts expect sales will grow by 4.90% for the current quarter and 13.40% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 63.34% over the past 5 years.
HSDT Dividends
Helius Medical Technologies Inc is expected to release its next earnings report on 2024-Nov-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
Insiders own 0.61% of the company shares, while shares held by institutions stand at 8.31% with a share float percentage of 8.36%. Investors are also buoyed by the number of investors in a company, with Helius Medical Technologies Inc having a total of 17.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 30, 2024, the former fund manager holds about 0.39% shares in the company for having 13.78 shares of worth $11716.0 while later fund manager owns 12.6 shares of worth $10709.0 as of Mar 31, 2024, which makes it owner of about 0.35% of company’s outstanding stock.
